Moderna

From Simple English Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Moderna.png

Moderna is an American biotechnology company based in Cambridge, Massachusetts. They focus on drug discovery, drug development, and vaccine technologies based on messenger RNA (mRNA).[1]

As of November 2020, Moderna was valued at $35 billion, and while none of its drugs had been approved, its COVID-19 vaccine candidate was close to being authorized for mass use.[2]

References[change | change source]

  1. Catherine Shaffer (December 6, 2013). "Moderna Makes Entrance with $40M Round for mRNA Work". BioWorld. Archived from the original on November 16, 2020. Retrieved Dec 11, 2013.
  2. Kuznia, Robert; Polglase, Katie; Mezzofiore, Gianluca (1 May 2020). "In quest for vaccine, US makes 'big bet' on company with unproven technology". CNN Investigates. Archived from the original on 16 November 2020. Retrieved 1 May 2020.